在前列腺切除术后的患者接受救援放射治疗后,受惩罚生存的诺莫图预测了5年无转移的生存期:一项多中心研究
F Mastroleo1, R Villa1, M Zaffaroni2
1Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Clinical genitourinary cancer
|September 13, 2025
概括
这项研究开发了一种预测性名谱,用于估计前列腺癌复发的救援放射治疗 (SRT) 后的5年远程无转移生存期 (DMFS). 诺米图有助于对接受SRT治疗的患者进行个性化风险评估.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 尿道瘤学 尿道瘤学
背景情况:
- 救援放射疗法 (SRT) 在急性前列腺切除术后的生化复发 (BCR) 中至关重要.
- 许多接受SRT治疗的患者仍然进展到远程转移.
- 预测这种进展对于患者管理至关重要.
研究的目的:
- 开发和验证预测SRT治疗患者5年远程无转移存活率 (DMFS) 的名图.
- 确定SRT后远程转移的关键预测因素.
- 为了实现个性化的风险分层,以改善患者的治疗结果.
主要方法:
- 在RP后对1720名接受SRT用于BCR的患者进行了多中心回顾性分析.
- 开发一个具有内部和外部验证的处罚生存名录.
- 根据预测得分将患者分为风险组的分层.
主要成果:
- 5年的DMFS率为84%.
- 远程转移的独立预测因素包括pT3/pT4阶段,ISUP等级组4/5,以及手术后12个月内SRT.
- 在外部验证后,该名录显示出良好的预测准确性,C指数为0.70.
结论:
- 一个外部验证的名图可以准确地预测SRT患者的5年DMFS.
- 该工具为高风险个人提供了个性化风险评估.
- 它支持针对SRT后患者的量身定制的监测和治疗策略.
更多相关视频
相关概念视频
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
Kaplan-Meier Approach
526
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
526


